149 related articles for article (PubMed ID: 16447066)
1. Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt-Hogg-Dubé syndrome.
Kouchi M; Okimoto K; Matsumoto I; Tanaka K; Yasuba M; Hino O
Virchows Arch; 2006 Apr; 448(4):463-71. PubMed ID: 16447066
[TBL] [Abstract][Full Text] [Related]
2. A germ-line insertion in the Birt-Hogg-Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer.
Okimoto K; Sakurai J; Kobayashi T; Mitani H; Hirayama Y; Nickerson ML; Warren MB; Zbar B; Schmidt LS; Hino O
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2023-7. PubMed ID: 14769940
[TBL] [Abstract][Full Text] [Related]
3. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Nihon rat model by introduction of a wild-type Bhd gene.
Togashi Y; Kobayashi T; Momose S; Ueda M; Okimoto K; Hino O
Oncogene; 2006 May; 25(20):2885-9. PubMed ID: 16369488
[TBL] [Abstract][Full Text] [Related]
4. Natural history of the Nihon rat model of BHD.
Okimoto K; Kouchi M; Matsumoto I; Sakurai J; Kobayashi T; Hino O
Curr Mol Med; 2004 Dec; 4(8):887-93. PubMed ID: 15579036
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
Murakami T; Sano F; Huang Y; Komiya A; Baba M; Osada Y; Nagashima Y; Kondo K; Nakaigawa N; Miura T; Kubota Y; Yao M; Kishida T
J Pathol; 2007 Apr; 211(5):524-531. PubMed ID: 17323425
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous renal tubular hyperplastic and neoplastic lesions in three Sprague-Dawley rats from a 90-day toxicity study.
Hall WC; Elder B; Walker CL; Cai SL; Peters DG; Goodman DG; Ulland BM; Borzelleca JF
Toxicol Pathol; 2007 Feb; 35(2):233-41. PubMed ID: 17366317
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
9. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
Schmidt LS
Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
[TBL] [Abstract][Full Text] [Related]
11. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
Schmidt LS; Nickerson ML; Warren MB; Glenn GM; Toro JR; Merino MJ; Turner ML; Choyke PL; Sharma N; Peterson J; Morrison P; Maher ER; Walther MM; Zbar B; Linehan WM
Am J Hum Genet; 2005 Jun; 76(6):1023-33. PubMed ID: 15852235
[TBL] [Abstract][Full Text] [Related]
12. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.
Adley BP; Smith ND; Nayar R; Yang XJ
Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of renal carcinoma cell lines from a Bhd gene mutant (Nihon) rat.
Matsumoto I; Kouchi M; Okimoto K; Kijima K; Ueda T; Hirayama Y; Inoue T; Seki T; Hino O
Tumour Biol; 2009; 30(5-6):249-56. PubMed ID: 19816092
[TBL] [Abstract][Full Text] [Related]
15. Birt-Hogg-Dubé syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrum.
Furuya M; Hasumi H; Yao M; Nagashima Y
Cancer Sci; 2020 Jan; 111(1):15-22. PubMed ID: 31777168
[TBL] [Abstract][Full Text] [Related]
16. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
17. Multiple/bilateral renal tumors in patients with Birt-Hogg-Dubé syndrome.
Fahmy W; Safwat AS; Bissada NK; Curry N; Guirguis N; Clarke HS; Fraig M; Finkbeiner A
Int Urol Nephrol; 2007; 39(4):995-9. PubMed ID: 17211573
[TBL] [Abstract][Full Text] [Related]
18. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax.
Gunji Y; Akiyoshi T; Sato T; Kurihara M; Tominaga S; Takahashi K; Seyama K
J Med Genet; 2007 Sep; 44(9):588-93. PubMed ID: 17496196
[TBL] [Abstract][Full Text] [Related]
20. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
